醫(yī)學(xué)免疫學(xué)復(fù)習(xí)資料:試卷H和答案_第1頁(yè)
醫(yī)學(xué)免疫學(xué)復(fù)習(xí)資料:試卷H和答案_第2頁(yè)
醫(yī)學(xué)免疫學(xué)復(fù)習(xí)資料:試卷H和答案_第3頁(yè)
醫(yī)學(xué)免疫學(xué)復(fù)習(xí)資料:試卷H和答案_第4頁(yè)
醫(yī)學(xué)免疫學(xué)復(fù)習(xí)資料:試卷H和答案_第5頁(yè)
全文預(yù)覽已結(jié)束

下載本文檔

版權(quán)說(shuō)明:本文檔由用戶(hù)提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

蘇州大學(xué)《免疫學(xué)》H卷Multiplechoicequestions(2’×25)1.WhichcytokinecanpromoteTcellproliferationanddifferentiationA.IL-1B.IL-2C.IL-3D.G-CSFE.TGF-β2.WhichoneofthefollowingcandirectlyandspecificallykilltargetcellsA.THcellsB.TccellsC.NKcellsD.MacrophagesE.neutrophils3.Bloodtransfusionreactionscausedbymis-mathchedbloodtransfusionbelongstoA.typeIhypersensitivereactionB.typeIIhypersensitivereactionC.typeIIIhypersensitivereactionD.typeIVhypersensitivereaction4.WhichkindofcytokinecontributestoBcellantibodyclassswitchingtoIgEA.IL-1B.IL-2C.TGF-βD.IL-4E.IL-55.Auto-reactivelymphocyteclonesaremainlydeletedinA.ThymusB.BoneMarrowC.SpleenD.BonemarrowandThymus6.PhagocytosisA.iscarriedbycellsoftheadaptiveimmunesystemB.isrestrictedtomacrophagesC.isimportantinbacterialinfectionsD.isaprocessthatdoesnotinvolveenergyE.resultsindivisionofthecellDendriticcellsarecharacterizedbyA.thepresenceofmajorbasicproteinsB.expressionofCD3C.expressionofIgMmoleculesD.theirabilitytoreleasehistamineE.theirinterfacebetweentheinnateandadaptiveimmunesystems8ActivationofthealternativepathwayinvolvesA.C1B.C2C.C3D.C49.BcellsaredistinguishedfromTcellsbythepresenceofA.CD3B.CD4C.CD8D.surfaceIgE.classIMHCantigen10.AllotypesareA.antigenicdeterminantswhichsegregatewithinaspeciesB.criticaltothefunctionoftheantibodycombiningsiteC.involvedinspecificityD.involvedinmemory11.TheFabportionofIgA.bindstoaFcreceptorB.containstheJchainC.containstheidiotypeoftheIgD.mediatesbiologicaleffectorfunctionsofAbmolecules(plementactivation)12.Antibodydependentcellmediatedcytotoxicity(ADCC)A.iscarriedoutbyBcellsB.isthemainmechanismforkillingintracellularmicrobesC.involvesFcreceptorsontheeffectorcellsD.isprimarilymediatedbyIgEantibody13.ViralreplicationwithincellsisinhibitedbyA.IL-13B.IL-1C.IFN-D.TNF-E.IL-414.CytotoxicTcellsgenerallyrecognizeantigeninassociationwithA.ClassIMHCdeterminantsB.ClassIIMHCdeterminantsC.ClassIIIMHCdeterminantsD.HLA-DRdeterminants15.Allofthefollowingaretrueaboutreceptorsoftheinnateimmunesystem,EXCEPTthattheyA.includethoseoftheTollfamilyB.recognizemolecularpatternsassociatedwithgroupsofmicrobesC.includeCD14andscavengerreceptorsD.includeMHCmoleculesE.donotincludeIgandIg16.AllofthefollowingaretrueaboutclassswitchingofantibodiesEXCEPTthatA.particularThsubsetsarerequiredB.itoccursingerminalcentersolymphnodesC.cytokinesarerequiredD.itoccursinpatientswithDiGeorgesyndromeE.itdoesnotoccurinpatientswithageneticdefectinCD40L17.CTLA.donotmediatecytotoxicityofotherTcellsinfectedwithvirusB.mediatekillingbyinsertionofperforinintothemembraneofthetargetcellC.donotneedtorecognizedMHCantigensonthetargetcelltokillD.recognizeantigenswithMHCIImoleculesE.normallyhelpBcellstomakeantibodies18.Super-antigensA.activatelargenumbersofTcellsbydirectlybindingtotheTCRchainandclassIIMHCB.arehighmolecularweightantigensthatcantriggerTcellproliferationintheabsenceofantigen-presentingcellsC.canactivateallBcellsbybindingtoIgMD.canonlytriggerCD8+Tcells19.ThestageinB-celldevelopmentatwhichtolerancecanbemosteasilyinducedisA.memoryBB.pre-BC.immatureBD.plasmacellE.matureB20.TheprocessinvolvedinallowingTcellstosurviveinthethymusisA.positiveselectionB.negativeselectionC.apoptosisD.necrosisE.complementinactivation21.TumorimmunesurveillancemaybemediatedbyA.mastcellsB.neutrophilsC.LangerhanscellsD.NKcells22.ImmediatehypersensitivityusuallyinvolvesA.mastcellsB.antibodiestomastcellsC.plateletsD.IgG23.Thepredominantantigenpresentingcellincontacthypersensitivity(e.g.poisonivy)istheA.TlymphocyteB.BlymphocyteC.basophilD.LangerhanscellE.NKcell24.DelayedhypersensitivityastypifiedbytheMantouxreactiontotuberculinismediatedbyA.lymphocytesB.polymorphonuclearcellsC.anaphylacticantibodiesD.complementbindingantibodiesE.antigen-antibodycomplexes25.ELISAassayA.resultsincelllysisB.usesaradiolabeledsecondantibodyC.involvesadditionofsubstratewhichisconvertedtoacoloredend-productD.requiressensitizedredbloodcellsExplainterms(6’×5)1.Adaptiveimmunity2.Complement:3.TCR4.MHC5.oncofetalantigensBigquestions(10’×2)1.Pleasedescribethestructureandfunctionsofantibody.2.2-signaltheoryforTcellactivation.Immunology(H)multiplechoicequestions(2’×25)BBBDDCECDACCCADDBACADADACB.explainterms(6’×5)1.“Adaptiveimmunity”isprovidedbyT&Blymphocytes(1’).Itisthe2ndlineofdefense.(1’)Ithastwoimportantcharacteristics:Immuneresponseishighlyspecificfortheantigenthattriggereditandhasmemorytotheantigen.Exposuretoantigencreatesanimmunologic“memory.”(3’)2.Complement:Thecomplementsystemisanimportantcomponentofinnateimmunity(2’).Complementwas1stdescribedin1890sasaheat-labilecomponentofnormalplasma,thataugmentsopsonizationofbacteriabyantibodiesandallowssomeantibodiestokillbacteria(1’).Complementisagroupofproteinsthatformtheprincipaleffectorarmofthehumoralimmunesystem(1’).Itcanbeactivatedbytheclassicalandalternativepathways,bothpathwayswilleventuallyleadtothelyticpathwaywhichfeaturedbytheformationofMAC(2’).3.TCRTcellreceptor(1’).TcellreceptorissimilarinstructuretoImmunoglobulins(similartoasingleFabfragment(2’).Composedoftwoglycoproteinchains(/or/)(1’).MostmatureTcellshaveTCRscomposedofanchainandachain(theyarecalled/Tcells).ThefunctionistorecognizeMHC/peptideandthenactivateTcells.Itisimportantforprovidingthe1stsignalforTcellactivation.(2’)4.MHCmajorhistocompatibilitycomplex(2’)Itwasidentifiedthatthehistocompatibility(theabilitytoacceptgraftsfromanotherindividual)dependedonthedonorandrecipientsharingthesameMHCgenetype(2’).Itwasprovedthenthatthegeneisaverylarge,containingmorethan100separategeneloci,butthemoleculeswhichdeterminegraftrejectionarealimitedgrouptermedclassIandclassIIMHCgenesthatmapneartoeachotheronasinglechromosome.(2’)That'swheretheterm,majorhistocompatibilitycomplexcomesfrom.5,OncofetalantigensarethusnotTSAnoristheirpresent,(1’)evenathighconcentration,intheserumdiagnosticofcancer,becausehighlevelscanresultfromnon-neoplasticdiseasesincludingchronicinflammationofthebowelorcirrhosisoftheliver.(2’)However,thequantitationofthesemoleculesintheserumcanbeusedtoevaluatethetumorburdenandeffectivenessofdrugtreatment.(2’)C.bigquestions(10’×2)1.structureandfunctionsofantibody.Structure:(indication---H,Lchains,V,Cregions,CDRs,FRs)TheN-terminalendofIgischaracterizedbysequencevariability(V)inboththeheavyandlightchains,referredtoastheVHandVLregionsrespectively.Therestofthemoleculehasarelativelyconstant(C)structure.(1’)TheconstantportionofthelightchainistermedtheCLregion.Theconstantportionoftheheavychainisfurtherdividedintothreestructurallydiscreteregions:CH1,CH2andCH3.Theseglobularregions,whicharestabilizedbyintrachaindisulphidebonds,arereferredtoas‘domains’.Thesitesatwhichtheantibodybindsantigenarelocatedinthevariabledomains.ThehingeregionisasegmentofheavychainbetweentheCH1andCH2domains.Flexibilityinthisareapermitsthetwoantigen-bindingsitestooperateindependently(2’).Attheaminoacidlevel,thevariableregioniscomprisedofthreeregionsofextremevariability(hyervaribleregion).Theyarecalledcomplementarity-determiningregions,orCDRs.(1’)InterspersedamongtheCDRsareframeworkregions(FRs)whicharelessvariableandmoreevolutionarilyconserved.Atthethree-dimensionallevel,thethreeCDRsofeachchainconvergetoformacombiningsitewhichrecognizetheantigenicdeterminant(epitope)(1’).Functions:Theroleofantibodyalone------neutralization(1’)NEUTRALIZATIONOFTOXINSANDVENOMS,OFVIRUSESANDBACTERIAPREVENTATTACHMENTTOCELLRECEPTORSRoleofantibodyincomplementactivation(1’)ACTIVATIONOFCOMPLEMENT–IgM(mosteffective)andmostsubclassesofIgGcanactivatecomplement.Roleofantibodywitheffectorcells-----phagocytes,NKcells(1’)OPSONIZATION–thepromotionofphagocytosisofantigensbymacrophagesandneutrophils.ProteinmoleculescalledFcreceptors(FcR),whichbindtheconstantregionofmostclassesofantibodyarepresentonthesurfacesofphagocytes.ANTIBODY-DEPENDENTCELL-MEDIATEDCYTOTOXICI

溫馨提示

  • 1. 本站所有資源如無(wú)特殊說(shuō)明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶(hù)所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁(yè)內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒(méi)有圖紙預(yù)覽就沒(méi)有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫(kù)網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶(hù)上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶(hù)上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶(hù)因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論